rBC2LCN lectin as a potential probe of early‐stage HER2‐positive breast carcinoma

rBC2LCN lectin as a potential probe of early‐stage HER2‐positive breast carcinoma

The recombinant N‐terminal domain of BC2L‐C lectin (rBC2LCN) is useful for detecting not only human pluripotent stem cells but also some cancers. However, the cancer types and stages that can be detected by rBC2LCN remain unclear. In this study, we identified the human breast carcinoma subtypes and...

Full description

Bibliographic Details
Main Authors: Shuuji Mawaribuchi, Yoshikazu Haramoto, Hiroaki Tateno, Yasuko Onuma, Yasuhiko Aiki, Yuzuru Ito
Format: Article
Language:English
Published: Wiley 2020-06-01
Series:FEBS Open Bio
Subjects:
breast carcinoma
epithelial‐to‐mesenchymal transition
HER2
lectin
rBC2LCN
Online Access:https://doi.org/10.1002/2211-5463.12852

Similar Items

Similar Items